Boekhorst Paul Francis Olivier Te
President and CEO at ImmuCell Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: ImmuCell Corporation, 1 year.
Chief executive roles
Mixed · grade D
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 59
4.3% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 12, 2026 | ImmuCell Corporation | Option exercise | +16,393 | $6.10 | $99,997 |
| Jun 18, 2026 | ImmuCell Corporation | Open-market purchase | +8,000 | $9.50 | $76,000 |
| Dec 3, 2025 | ImmuCell Corporation | Open-market purchase | +2,556 | $5.00 | $12,780 |
| Dec 3, 2025 | ImmuCell Corporation | Open-market purchase | +3,521 | $5.04 | $17,746 |
| Dec 2, 2025 | ImmuCell Corporation | Open-market purchase | +3,708 | $4.87 | $18,058 |
Questions about Boekhorst Paul Francis Olivier Te
What boards is Boekhorst Paul Francis Olivier Te on?
Boekhorst Paul Francis Olivier Te sits on the board of ImmuCell Corporation.
What company is Boekhorst Paul Francis Olivier Te the CEO of?
Boekhorst Paul Francis Olivier Te has been President and CEO of ImmuCell Corporation since October 2025.
How long has Boekhorst Paul Francis Olivier Te served on boards?
Our records show at least 1 year of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.